GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Common Stock

Mydecine Innovations Group (STU:0NF0) Common Stock : €86.57 Mil (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Common Stock?

Mydecine Innovations Group's quarterly common stock increased from Mar. 2023 (€81.31 Mil) to Jun. 2023 (€84.25 Mil) and increased from Jun. 2023 (€84.25 Mil) to Sep. 2023 (€86.57 Mil).

Mydecine Innovations Group's annual common stock increased from Dec. 2020 (€54.74 Mil) to Dec. 2021 (€74.44 Mil) and increased from Dec. 2021 (€74.44 Mil) to Dec. 2022 (€80.55 Mil).


Mydecine Innovations Group Common Stock Historical Data

The historical data trend for Mydecine Innovations Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Common Stock Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.14 42.62 54.74 74.44 80.55

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.83 80.55 81.31 84.25 86.57

Mydecine Innovations Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Mydecine Innovations Group (STU:0NF0) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines